miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer (Q103760252)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33253979%20AND%20SRC:MED&resulttype=core&format=json

3 December 2020

title

miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33253979%20AND%20SRC:MED&resulttype=core&format=json

3 December 2020

author name string

Shen Zhong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33253979%20AND%20SRC:MED&resulttype=core&format=json

3 December 2020

Heiko Golpon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33253979%20AND%20SRC:MED&resulttype=core&format=json

3 December 2020

Patrick Zardo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33253979%20AND%20SRC:MED&resulttype=core&format=json

3 December 2020

Jürgen Borlak

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33253979%20AND%20SRC:MED&resulttype=core&format=json

3 December 2020

publication date

27 November 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33253979%20AND%20SRC:MED&resulttype=core&format=json

3 December 2020

published in

Translational Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33253979%20AND%20SRC:MED&resulttype=core&format=json

3 December 2020

cites work

Cancer statistics, 2020

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Reduced lung-cancer mortality with low-dose computed tomographic screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Complications of CT-guided transthoracic lung biopsy : A short report on current literature and a case of systemic air embolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

The Basic Principles of FDG-PET/CT Imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Role of PET/CT for precision medicine in lung cancer: perspective of the Society of Nuclear Medicine and Molecular Imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

The role of positron emission tomography in the diagnosis, staging and response assessment of non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

[18F]Fluorodeoxyglucose PET in Thoracic Malignancies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA genes are transcribed by RNA polymerase II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Role of microRNAs in translation regulation and cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

A Five-miRNA Panel Identified From a Multicentric Case-control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: Clinical significance of miR-23b-3p deregulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miRNA expression profiling of lung adenocarcinomas: correlation with mutational status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Clinical value of miR-452-5p expression in lung adenocarcinoma: A retrospective quantitative real-time polymerase chain reaction study and verification based on The Cancer Genome Atlas and Gene Expression Omnibus databases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Clinic significance of microRNA-99a expression in human lung adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Overexpression of miR-939-3p predicts poor prognosis and promotes progression in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Clinical Significance of miR-210 and its Prospective Signaling Pathways in Non-Small Cell Lung Cancer: Evidence from Gene Expression Omnibus and the Cancer Genome Atlas Data Mining with 2763 Samples and Validation via Real-Time Quantitative PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Seven-microRNA panel for lung adenocarcinoma early diagnosis in patients presenting with ground-glass nodules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA expression profiling of lung adenocarcinoma in Xuanwei, China: A preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Expression of miRNA-26b in the diagnosis and prognosis of patients with non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

The Expression of miR-375 Is Associated with Carcinogenesis in Three Subtypes of Lung Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Identification of miR‑124a as a novel diagnostic and prognostic biomarker in non‑small cell lung cancer for chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

An integrated analysis of miRNA and mRNA expressions in non-small cell lung cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA-222 expression and its prognostic potential in non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Differentially expressed microRNAs in small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-1290 promotes lung adenocarcinoma cell proliferation and invasion by targeting SOCS4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Underexpression of miR-486-5p but not Overexpression of miR-155 is Associated with Lung Cancer Stages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Identification of microRNA-615-3p as a novel tumor suppressor in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA classifiers for predicting prognosis of squamous cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Low miR-145 expression level is associated with poor pathological differentiation and poor prognosis in non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Increased expression of microRNA-301a in nonsmall-cell lung cancer and its clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Expression of miR-150 and miR-3940-5p is reduced in non-small cell lung carcinoma and correlates with clinicopathological features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Differentially Expressed miRNAs in Tumor, Adjacent, and Normal Tissues of Lung Adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Involvement of dual-strand of the miR-144 duplex and their targets in the pathogenesis of lung squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Expression and clinical evidence of miR-494 and PTEN in non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA-148b is a potential prognostic biomarker and predictor of response to radiotherapy in non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Overexpression of microRNA-423-3p indicates poor prognosis and promotes cell proliferation, migration, and invasion of lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Decreased expression of miR216a contributes to non-small-cell lung cancer progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Expression of miRNA-130a in nonsmall cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

The expression and function of miRNA-451 in non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Down-regulation of miR-133a as a poor prognosticator in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Endogenous microRNA-424 predicts clinical outcome and its inhibition acts as cancer suppressor in human non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Expression and clinical significance of miR-139-5p in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Diagnostic Value of MiR-125b as a Potential Biomarker for Stage I Lung Adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Correlation between the expression levels of miR-1 and PIK3CA in non-small-cell lung cancer and their relationship with clinical characteristics and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Expression profile analysis of microRNAs and downregulated miR-486-5p and miR-30a-5p in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Serum miR-223: A Validated Biomarker for Detection of Early-Stage Non-Small Cell Lung Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Prognostic potential of microRNA-138 and its target mRNA PDK1 in sera for patients with non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Deregulation of serum microRNA expression is associated with cigarette smoking and lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Serum miR-499 as a novel diagnostic and prognostic biomarker in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Prognostic significance of serum microRNA-210 levels in nonsmall-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

A cluster of specified microRNAs in peripheral blood as biomarkers for metastatic non-small-cell lung cancer by stem-loop RT-PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Identification of A Panel of Serum microRNAs as Biomarkers for Early Detection of Lung Adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-Test: A Blood Test for Lung Cancer Early Detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

A Novel Serum 4-microRNA Signature for Lung Cancer Detection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Increased micro-RNA 17, 21, and 192 gene expressions improve early diagnosis in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Serum miR-210-3p as a Potential Noninvasive Biomarker of Lung Adenocarcinoma: A Preliminary Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Blood-borne miRNA profile-based diagnostic classifier for lung adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Low serum miR-98 as an unfavorable prognostic biomarker in patients with non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Identification of miRNAs as non-invasive biomarkers for early diagnosis of lung cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Identification and evaluation of 2 circulating microRNAs for non-small cell lung cancer diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Serum levels of miR-19b and miR-146a as prognostic biomarkers for non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Validation of a serum 4-microRNA signature for the detection of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Application of serum microRNA-9-5p, 21-5p, and 223-3p combined with tumor markers in the diagnosis of non-small-cell lung cancer in Yunnan in southwestern China.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

A three-microRNA signature for lung squamous cell carcinoma diagnosis in Chinese male patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Combination of serum miRNAs with Cyfra21-1 for the diagnosis of non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MiR-520f acts as a biomarker for the diagnosis of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Serum microRNA-135a as a diagnostic biomarker in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

A plasma miRNA signature for lung cancer early detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

A Direct Plasma miRNA Assay for Early Detection and Histological Classification of Lung Cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

External validation of a panel of plasma microRNA biomarkers for lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Plasma miR-30a-5p as an early novel noninvasive diagnostic and prognostic biomarker for lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Two plasma microRNA panels for diagnosis and subtype discrimination of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Circulating plasma microRNAs as potential biomarkers of non-small cell lung cancer obtained by high-throughput real-time PCR profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Application of plasma circulating microRNA-448, 506, 4316, and 4478 analysis for non-invasive diagnosis of lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Identification of four plasma microRNAs as potential biomarkers in the diagnosis of male lung squamous cell carcinoma patients in China.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Plasma microRNAs as potential biomarkers for non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Circulating microRNA-339-5p and -21 in plasma as an early detection predictors of lung adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Clinical significance of the expression of miRNA-21, miRNA-31 and miRNA-let7 in patients with lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Role of plasma MicroRNAs in the early diagnosis of non-small-cell lung cancers: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Identification of a three-miRNA signature as a blood-borne diagnostic marker for early diagnosis of lung adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

The role of plasma miRNAs in the diagnosis of pulmonary nodules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Combining Plasma miRNAs and Computed Tomography Features to Differentiate the Nature of Pulmonary Nodules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Expression and significance of circulating microRNA-31 in lung cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

A panel of miRNAs derived from plasma extracellular vesicles as novel diagnostic biomarkers of lung adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Decreased circulating miR-375: a potential biomarker for patients with non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Plasma miR-92a-2 as a biomarker for small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Plasma miR-19b and miR-183 as Potential Biomarkers of Lung Cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Plasma miR-145, miR-20a, miR-21 and miR-223 as novel biomarkers for screening early-stage non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Predictive value of microRNA-10b expression in peripheral blood mononuclear cells in evaluating short- and long-term efficacy of chemotherapy for patients with advanced non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

A combined panel of circulating microRNA as a diagnostic tool for detection of the non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

A panel of noncoding RNAs in non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA expression profiling of sputum for the detection of early and locally advanced non-small-cell lung cancer: a prospective case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Sputum microRNA profiling: a novel approach for the early detection of non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Analysis of MicroRNAs in sputum to improve computed tomography for lung cancer diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Prognostic significance of serum miR-17-5p in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Serum level of microRNA-147 as diagnostic biomarker in human non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Clinical evaluation of microRNA expression profiling in non small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Tissue-specific and plasma microRNA profiles could be promising biomarkers of histological classification and TNM stage in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Differential expression of miR-125a-5p and let-7e predicts the progression and prognosis of non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MiR-183-5p is required for non-small cell lung cancer progression by repressing PTEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA-223 Suppresses the Canonical NF-κB Pathway in Basal Keratinocytes to Dampen Neutrophilic Inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

The MicroRNA-183-96-182 Cluster Promotes T Helper 17 Cell Pathogenicity by Negatively Regulating Transcription Factor Foxo1 Expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Sp1-mediated microRNA-182 expression regulates lung cancer progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

c-Myc-regulated microRNAs modulate E2F1 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

HBeAg-induced miR-106b promotes cell growth by targeting the retinoblastoma gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Circulating microRNAs predict the response to anti-PD-1 therapy in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in wild-type advanced non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Treatment of stage IV non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Evaluation of plasma microRNA levels to predict insensitivity of patients with advanced lung adenocarcinomas to pemetrexed and platinum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

The Effect of Advances in Lung-Cancer Treatment on Population Mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Circulating MicroRNA Biomarkers for Lung Cancer Detection in East Asian Populations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Immunotherapy in patients with early stage resectable nonsmall cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC): the NEOMUN trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Processes of discontinuing chemotherapy for metastatic non-small-cell lung cancer at the end of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

BAP1 suppresses lung cancer progression and is inhibited by miR-31

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Immune evasion by TGFβ-induced miR-183 repression of MICA/B expression in human lung tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Zinc finger E-box-binding homeobox 2 (ZEB2) regulated by miR-200b contributes to multi-drug resistance of small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-200b inhibits migration and invasion in non-small cell lung cancer cells via targeting FSCN1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-486-5p functions as an oncogene by targeting PTEN in non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MiRNA-21: a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3'UTR and predicts poor survival in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-17-5p downregulation contributes to paclitaxel resistance of lung cancer cells through altering beclin1 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA-650 was a prognostic factor in human lung adenocarcinoma and confers the docetaxel chemoresistance of lung adenocarcinoma cells via regulating Bcl-2/Bax expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-141 regulation of EIF4E expression affects docetaxel chemoresistance of non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

MicroRNA 25, microRNA 145, and microRNA 210 as biomarkers for predicting the efficacy of maintenance treatment with pemetrexed in lung adenocarcinoma patients who are negative for epidermal growth factor receptor mutations or anaplastic lymphoma kin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

Clinical significance of miRNA - 106a in non-small cell lung cancer patients who received cisplatin combined with gemcitabine chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2020.11.012

10.1016/J.TRSL.2020.11.012

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33253979%20AND%20SRC:MED&resulttype=core&format=json

3 December 2020

1 reference